|View printer-friendly version|
|Array BioPharma Inc. to Report Second Quarter Earnings for Fiscal Year 2001 On February 5th, 2001|
BOULDER, Colo., Feb. 1 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today that the company will report earnings for the second quarter of fiscal year 2001 on Monday, February 5, 2001 at 4.30 p.m. eastern time and hold a conference call at 9.00 a.m. eastern time on Tuesday, February 6, 2001. Robert E. Conway, Chief Executive Officer and R. Michael Carruthers, Chief Financial Officer, will lead the call.
Toll-free: (800) 946 0744 Toll: (719) 457 2651 Web cast: www.arraybiopharma.com
The conference call will be replayed for one week and can be accessed by dialing toll-free (888) 203 1112, and outside the US (719) 457 0820. The access code is 749530.
Array BioPharma is a drug discovery company creating new drugs through innovations in chemistry and structural biology. Array's competitive advantage is its world-class scientific team that integrates chemistry and structural-biology with an information-based technology platform to create higher quality drug candidates targeting multiple therapeutic areas. Array provides drug discovery expertise to collaborators and for its own proprietary research efforts. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com. SOURCE Array BioPharma Inc.
CONTACT: Joanna K. Money, Ph.D. of Array BioPharma Inc., 303-381 6676, email@example.com/